Fortaleza Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Fortaleza Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,585	Closed	-$886K	–	216
2016 Q2	$886K	Sell	7,585 -2,250	-23%	-$319K	0.72%	55
2016 Q1	$1.37M	Hold	9,835	–	–	0.87%	50
2015 Q4	$1.88M	Buy	9,835 +725	+8%	+$127K	1.13%	39
2015 Q3	$1.43M	Hold	9,110	–	–	1%	43
2015 Q2	$1.65M	Sell	9,110 -1,040	-10%	-$179K	0.99%	45
2015 Q1	$1.76M	Sell	10,150 -2,360	-19%	-$427K	0.99%	41
2014 Q4	$2.31M	Hold	12,510	–	–	1.06%	20
2014 Q3	$2.07M	Buy	12,510 +5,140	+70%	+$844K	0.97%	21
2014 Q2	$1.15M	Hold	7,370	–	–	0.53%	76
2014 Q1	$1.12M	Buy	7,370 +7,330	+18,325%	+$1.17M	0.57%	66
2013 Q4	$5K	Hold	40	–	–	﹤0.01%	177
2013 Q3	$5K	Buy	+40	New	+$4.39K	﹤0.01%	172

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fortaleza Asset Management's ALXN Position: Q3 2016 in Review

Fortaleza Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2016, closing a stake of 7,585 shares — an estimated $886K sold.

Fortaleza Asset Management first reported a position in ALXN in Q3 2013 and held it in 12 quarters. The position peaked at $2.31M in Q4 2014. 519 funds tracked by Wall St. Rank hold ALXN as of Q3 2016.

Fortaleza Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Fortaleza Asset Management sold 7,585 Alexion Pharmaceuticals shares in Q3 2016, an estimated $886K.
Fortaleza Asset Management first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 12 quarters.
Fortaleza Asset Management's Alexion Pharmaceuticals position peaked at $2.31M in Q4 2014.
519 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2016.

Based on Fortaleza Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.